CTOs on the Move

Innovative Medical Device Solutions (IMDS)

www.imds.net

 
IMDS (Innovative Medical Device Solutions) provides comprehensive product development and supply chain management solutions for medical device companies, with a focus on the orthopedic industry. IMDS is the integration of the following companies: Leis
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imds.net
  • 13600 Heritage Pkwy Ste 170
    Fort Worth, TX USA 76177
  • Phone: 877.583.0677

Executives

Name Title Contact Details

Similar Companies

NutraOne

NutraOne was created for two groups of people: our customers and our retailers. Our mission is to always provide the quality product you demand at the most affordable price possible.

Expresso

Expresso fitness headquartered in Santa Clara, CA is the industry leader in gamified fitness for the commercial market. Over the past 15 years, Expresso has brought millions of riders adventure, challenges and community on their world class interactive connected bikes. The company is on a mission to bring people together through fitness with innovative, social, and immersive workouts. With over 100 million workouts where members ride in virtual worlds, push themselves with heart rate training, and HIIT workouts inspired by gaming, the company is well on its way to make that happen.

BioMedica Diagnostics

BioMedica Diagnostics Inc. is a Windsor, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Best Formulations

Best Formulations is a Rowland Heights, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.